Free Trial
NASDAQ:ULBI

Ultralife (ULBI) Stock Price, News & Analysis

Ultralife logo
$6.58 +0.08 (+1.23%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$6.58 0.00 (0.00%)
As of 06/12/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Ultralife Stock (NASDAQ:ULBI)

Advanced

Key Stats

Today's Range
$6.51
$6.80
50-Day Range
$5.88
$7.95
52-Week Range
$4.90
$9.52
Volume
15,299 shs
Average Volume
59,998 shs
Market Capitalization
$109.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Ultralife Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

ULBI MarketRank™: 

Ultralife scored higher than 32% of companies evaluated by MarketBeat, and ranked 492nd out of 629 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ultralife has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Ultralife has only been the subject of 1 research reports in the past 90 days.

  • Read more about Ultralife's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ultralife is -13.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ultralife is -13.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ultralife has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ultralife's valuation and earnings.
  • Percentage of Shares Shorted

    0.93% of the float of Ultralife has been sold short.
  • Short Interest Ratio / Days to Cover

    Ultralife has a short interest ratio ("days to cover") of 0.88, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ultralife has recently increased by 1.23%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Ultralife does not currently pay a dividend.

  • Dividend Growth

    Ultralife does not have a long track record of dividend growth.

  • News Sentiment

    Ultralife has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Ultralife this week, compared to 1 article on an average week.
  • Search Interest

    7 people have searched for ULBI on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Ultralife to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $714,928.00 in company stock, which represents 0.6522% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Ultralife insiders have bought more of their company's stock than they have sold. Specifically, they have bought $714,928.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    42.90% of the stock of Ultralife is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    30.68% of the stock of Ultralife is held by institutions.

  • Read more about Ultralife's insider trading history.
Receive ULBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ultralife and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ULBI Stock News Headlines

Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Ultralife Corporation Reports First Quarter Results
See More Headlines

ULBI Stock Analysis - Frequently Asked Questions

Ultralife's stock was trading at $5.72 at the beginning of 2026. Since then, ULBI stock has increased by 15.0% and is now trading at $6.58.

Ultralife Corporation (NASDAQ:ULBI) issued its earnings results on Friday, May, 8th. The technology company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by $0.18. The technology company had revenue of $47.45 million for the quarter, compared to the consensus estimate of $52.40 million. Ultralife had a negative net margin of 4.37% and a positive trailing twelve-month return on equity of 1.15%.
Read the conference call transcript
.

The following companies are subsidiaries of Ultralife: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries India Private Limited, Ultralife Batteries (UK) LTD, Ultralife Energy Services Corporation, and Ultralife UK LTD.

Top institutional investors of Ultralife include Dimensional Fund Advisors LP (5.97%), Janney Montgomery Scott LLC (3.11%), RBF Capital LLC (1.31%) and Renaissance Technologies LLC (1.19%). Insiders that own company stock include Bradford T Whitmore, Thomas Louis Saeli, W Shaw Robert, Michael Edward Manna and Janie Goddard.
View institutional ownership trends
.

Shares of ULBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ultralife investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Last Earnings
5/08/2026
Today
6/13/2026
Next Earnings (Estimated)
7/23/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
ELEC - MISC COMPONENTS
Sub-Industry
Electrical Equipment
Current Symbol
NASDAQ:ULBI
CIK
875657
Employees
560
Year Founded
1990

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.90 million
Net Margins
-4.37%
Pretax Margin
-6.13%
Return on Equity
1.15%
Return on Assets
0.70%

Debt

Debt-to-Equity Ratio
0.34
Current Ratio
2.56
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$191.16 million
Price / Sales
0.57
Cash Flow
$0.60 per share
Price / Cash Flow
10.94
Book Value
$7.82 per share
Price / Book
0.84

Miscellaneous

Outstanding Shares
16,660,000
Free Float
9,511,000
Market Cap
$109.62 million
Optionable
No Data
Beta
0.75

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:ULBI) was last updated on 6/13/2026 by MarketBeat.com Staff.
From Our Partners